Significant weight loss particularly reduction of visceral fat is associated with improvements in testosterone levels in men with obesity-related hypogonadism, as visceral fat drives conversion of testosterone to oestrogen
Fast Production Lead Time: Peak and off-season lead times are both within 15 working days
Structured history: timing, GI symptoms/dehydration, menopause/GSM risk, meds incl
The Phase 2 dose-finding trial (N=338), published in the New England Journal of Medicine in 2023 (DOI: 10.1056/NEJMoa2301972), randomized participants with obesity (BMI 30-50) to retatrutide at doses ranging from 0.5mg to 12mg weekly or placebo over 48 weeks
Click any schedule to view the full interactive simulation with projected drug levels over time
As you prepare for your next adventure, consider how important it is to maintain your health and well-being on the go